AbbVie Reports Second-Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSTR

Go back to AbbVie Reports Second-Quarter 2018 Financial Results

William Blair Remains Bullish on AbbVie (ABBV) Following 2Q Beat

July 30, 2018 8:45 AM EDT

William Blair reiterated an Outperform rating and $127.00 price target on Abbvie (NYSE: ABBV) following the company's 2Q earnings report. Revenues for the quarter were $8.3 billion, beating consensus of $8.2 billion. Non-GAAP EPS were $2.00, above consensus of $1.97.

Management issued updated guidance for 2018 non-GAAP EPS of $7.76 to $7.86... More

Abbvie (ABBV) PT Lowered to $110 at Cowen

July 27, 2018 11:57 AM EDT

Cowen lowered its price target on Abbvie (NYSE: ABBV) to $110.00 (from $130.00) while maintaining an Outperform rating following beat and raise.

The firm is lowering the target based on a reduced target PE of 14x 2018 EPS (prior 17x) given lingering uncertainties (legal, pricing,... More

AbbVie (ABBV) Tops Q2 EPS by 3c, Offers FY Guidance

July 27, 2018 7:39 AM EDT

AbbVie (NYSE: ABBV) reported Q2 EPS of $2.00, $0.03 better than the analyst estimate of $1.97. Revenue for the quarter came in at $8.28 billion versus the consensus estimate of $8.21 billion.

GUIDANCE:

AbbVie sees FY2018 EPS of $7.76-$7.86, versus the consensus of $7.81.

For earnings history and earnings-related data on AbbVie (ABBV) click here.

... More